193 related articles for article (PubMed ID: 34845375)
1. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
Lee YC; Lin SC; Yu G; Zhu M; Song JH; Rivera K; Pappin DJ; Logothetis CJ; Panaretakis T; Wang G; Yu-Lee LY; Lin SH
Oncogene; 2022 Feb; 41(6):757-769. PubMed ID: 34845375
[TBL] [Abstract][Full Text] [Related]
2. Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.
Yu G; Shen P; Lee YC; Pan J; Song JH; Pan T; Lin SC; Liang X; Wang G; Panaretakis T; Logothetis CJ; Gallick GE; Yu-Lee LY; Lin SH
iScience; 2021 Apr; 24(4):102388. PubMed ID: 33981975
[TBL] [Abstract][Full Text] [Related]
3. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-to-osteoblast transition in normal mouse bone development.
Lin SC; Yu G; Lee YC; Song JH; Song X; Zhang J; Panaretakis T; Logothetis CJ; Komatsu Y; Yu-Lee LY; Wang G; Lin SH
iScience; 2023 Feb; 26(2):105994. PubMed ID: 36798441
[TBL] [Abstract][Full Text] [Related]
5. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.
Lin SC; Lee YC; Yu G; Cheng CJ; Zhou X; Chu K; Murshed M; Le NT; Baseler L; Abe JI; Fujiwara K; deCrombrugghe B; Logothetis CJ; Gallick GE; Yu-Lee LY; Maity SN; Lin SH
Dev Cell; 2017 Jun; 41(5):467-480.e3. PubMed ID: 28586644
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
Yu G; Corn PG; Mak CSL; Liang X; Zhang M; Troncoso P; Song JH; Lin SC; Song X; Liu J; Zhang J; Logothetis CJ; Melancon MP; Panaretakis T; Wang G; Lin SH
bioRxiv; 2023 Dec; ():. PubMed ID: 38076845
[TBL] [Abstract][Full Text] [Related]
7. EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.
He S; Huang Q; Hu J; Li L; Xiao Y; Yu H; Han Z; Wang T; Zhou W; Wei H; Xiao J
Br J Cancer; 2019 Nov; 121(11):922-933. PubMed ID: 31649319
[TBL] [Abstract][Full Text] [Related]
8. BMP4 promotes prostate tumor growth in bone through osteogenesis.
Lee YC; Cheng CJ; Bilen MA; Lu JF; Satcher RL; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Cancer Res; 2011 Aug; 71(15):5194-203. PubMed ID: 21670081
[TBL] [Abstract][Full Text] [Related]
9. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.
Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovačević Ž
J Biol Chem; 2022 Mar; 298(3):101608. PubMed ID: 35065073
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells.
Nong Y; Wu D; Lin Y; Zhang Y; Bai L; Tang H
Am J Cancer Res; 2015; 5(2):782-91. PubMed ID: 25973315
[TBL] [Abstract][Full Text] [Related]
11. Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone.
Yu KJ; Li JK; Lee YC; Yu G; Lin SC; Pan T; Satcher RL; Titus MA; Yu-Lee LY; Weng WH; Gallick GE; Lin SH
Oncotarget; 2017 Sep; 8(43):74987-75006. PubMed ID: 29088840
[TBL] [Abstract][Full Text] [Related]
12. Osteoblastic Factors in Prostate Cancer Bone Metastasis.
Lin SC; Yu-Lee LY; Lin SH
Curr Osteoporos Rep; 2018 Dec; 16(6):642-647. PubMed ID: 30203251
[TBL] [Abstract][Full Text] [Related]
13. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
15. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
16. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
Qi W; Yang Z; Li H; Cui Y; Xuan Y
APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
[TBL] [Abstract][Full Text] [Related]
17. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition.
Sun Z; Schwenzer A; Rupp T; Murdamoothoo D; Vegliante R; Lefebvre O; Klein A; Hussenet T; Orend G
Cancer Res; 2018 Feb; 78(4):950-961. PubMed ID: 29259017
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
20. Microenvironmental Factors Drive Tenascin C and Src Cooperation to Promote Invadopodia Formation in Ewing Sarcoma.
Hawkins AG; Julian CM; Konzen S; Treichel S; Lawlor ER; Bailey KM
Neoplasia; 2019 Oct; 21(10):1063-1072. PubMed ID: 31521948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]